MFDS
- Status: likely_approved
🇰🇷 Cosmegen in South Korea
Cosmegen (DACTINOMYCIN) regulatory status in South Korea.
Marketing authorisation
Cosmegen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Cosmegen approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Cosmegen in South Korea?
Recordati is the originator. The local marketing authorisation holder may differ — check the official source linked above.